6 completed, 1 recruiting, 1 terminated. 3 Phase 2, 1 Early Phase 1, 1 Phase 1, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Early Phase 1 | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Terminated 1 |
| Phase 4 | 1 | Recruiting 1 |
Follow Retinal Telangiectasis: new trials by email Literature Review of Retinal Telangiectasis trials Research Report on Retinal Telangiectasis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of 18 mm Short Vitrectomy Probe for Pediatric Vitreoretinal Surgeries Pars plana vitrectomy with a 18 mm short vitrector - Retinopathy of Prematurity Both Eyes, Retinal Disease | Phase 4 | Recruiting | Chang Gung Memorial Hospital | 60 | 2024-03-05 | 2024-07-25 |
| DEXTENZA in Pediatric Patients Following Retinal Surgery or Laser Treatment Under Anesthesia Dextenza 0.4Mg Ophthalmic Insert, Pred Forte - Vitreoretinopathy, Coats' Disease | Early Phase 1 | Completed | Lejla Vajzovic, MD, FASRS | 15 | 2023-02-01 | 2026-04-23 |
| Interest of Intravitreal Injections of Anti-VEGF as Initial and Adjuvant Treatment in Coats Disease Anti-VEGF injections of bevacizumab, Laser - Retinal Telangiectasis, Coats Disease | Phase 3 | Terminated | Fondation Ophtalmologique Adolphe de Rothschild | 18 | 2019-10-24 | 2025-12-10 |
| Coats Plus Syndrome and LCC Syndrome: Series of 10 Pediatric Cases. Review of Literature and Natural History data collection - Coats Disease | Completed | University Hospital, Limoges | 10 | 2019-09-30 | 2020-03-17 | |
| A Study to Evaluate THR-317 Treatment for Macular Telangiectasia Type 1 (MacTel 1) THR-317 8mg - Retinal Telangiectasis, Idiopathic Juxtafoveal Retinal Telangiectasia | Phase 2 | Completed | ThromboGenics | 8 | 2018-09-18 | 2020-09-02 |
| Evaluation of Retinal and Vascular Features in Coats Disease After Intravitreal Injections of Ranibizumab Ranibizumab Injection - Coats Disease | Completed | Federico II University | 5 | 2016-01-01 | 2020-03-17 | |
| Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy ranibizumab injection (0.5 mg) - Coats' Disease, Idiopathic Retinal Telangiectasia | Phase 1 / Phase 2 | Completed | Manhattan Eye, Ear & Throat Hospital | 18 | 2007-05-01 | 2012-10-25 |
| Treatment of Congenital Telangiectasia (Coat's Disease) With Open-label Anecortave Acetate (15mg.) anecortave acetate - Coat's Disease | Phase 2 | Completed | Manhattan Eye, Ear & Throat Hospital | 4 | 2002-03-01 | 2012-10-24 |
Cysts (1) · Familial Exudative Vitreoretinopathies (1) · Idiopathic Juxtafoveal Retinal Telangiectasia (1) · Myopia, Degenerative (1) · Persistent Hyperplastic Primary Vitreous (1) · Polypoidal Choroidal Vasculopathy (1) · Pseudoxanthoma Elasticum (1) · Retinal Diseases (1) · Retinal Perforations (1) · Vitelliform Macular Dystrophy (1) · von Hippel-Lindau Disease (1)
Cardiovascular Diseases (8) · Eye Diseases (8) · Telangiectasis (8) · Vascular Diseases (8) · Retinal Diseases (7) · Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Eye Diseases, Hereditary (2) · Genetic Diseases, Inborn (2) · Pathological Conditions, Signs and Symptoms (2) · Abnormalities, Multiple (1) · Angiomatosis (1) · Choroid Diseases (1) · Choroidal Neovascularization (1) · Ciliopathies (1)
Ranibizumab (2) · Calcium Dobesilate (1) · Data Collection (1) · Lasers (1) · TB-403 (1) · anecortave acetate (1) · prednisolone acetate (1)
Manhattan Eye, Ear & Throat Hospital (2) · Chang Gung Memorial Hospital (1) · Federico II University (1) · Fondation Ophtalmologique Adolphe de Rothschild (1) · Lejla Vajzovic, MD, FASRS (1) · ThromboGenics (1) · University Hospital, Limoges (1)
France (3) · United States (3) · Italy (1) · Switzerland (1) · Taiwan (1)
Lawrence A. Yannuzzi, MD (2) · Daniela Montorio (1) · Gilda Cennamo (1) · Lejla Vajzovic, MD (1) · Wei-Chi Wu, MD, PhD (1)
2017 (1)